- Main
Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of early-stage lung cancer.
- Karimzadeh, Mehran;
- Momen-Roknabadi, Amir;
- Cavazos, Taylor;
- Fang, Yuqi;
- Chen, Nae-Chyun;
- Multhaup, Michael;
- Yen, Jennifer;
- Ku, Jeremy;
- Wang, Jieyang;
- Zhao, Xuan;
- Murzynowski, Philip;
- Wang, Kathleen;
- Hanna, Rose;
- Huang, Alice;
- Corti, Diana;
- Nguyen, Dang;
- Lam, Ti;
- Kilinc, Seda;
- Arensdorf, Patrick;
- Chau, Kimberly;
- Hartwig, Anna;
- Fish, Lisa;
- Li, Helen;
- Behsaz, Babak;
- Elemento, Olivier;
- Zou, James;
- Hormozdiari, Fereydoun;
- Alipanahi, Babak;
- Goodarzi, Hani
- et al.
Published Web Location
https://doi.org/10.1038/s41467-024-53851-9Abstract
Liquid biopsies have the potential to revolutionize cancer care through non-invasive early detection of tumors. Developing a robust liquid biopsy test requires collecting high-dimensional data from a large number of blood samples across heterogeneous groups of patients. We propose that the generative capability of variational auto-encoders enables learning a robust and generalizable signature of blood-based biomarkers. In this study, we analyze orphan non-coding RNAs (oncRNAs) from serum samples of 1050 individuals diagnosed with non-small cell lung cancer (NSCLC) at various stages, as well as sex-, age-, and BMI-matched controls. We demonstrate that our multi-task generative AI model, Orion, surpasses commonly used methods in both overall performance and generalizability to held-out datasets. Orion achieves an overall sensitivity of 94% (95% CI: 87%-98%) at 87% (95% CI: 81%-93%) specificity for cancer detection across all stages, outperforming the sensitivity of other methods on held-out validation datasets by more than ~ 30%.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-